pharmaceutical-investing Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares 20 November 2025
pharmaceutical-investing Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares 17 November 2025
